|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
no age specified
|
|
|
|
|
|
|
|
UMCT-1380
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
PHARMACIA-088050 NCI-V96-0828
|
|
|
|
|
|
|
|
Last Modified: 11/21/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Closed
|
|
|
|
0 to 21
|
|
|
|
NCI
|
|
|
|
POG-9404
|
|
|
|
|
|
|
|
Last Modified: 5/8/2007  First Published: 10/1/1996 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Closed
|
|
|
|
21 and under
|
|
|
|
NCI
|
|
|
|
POG-9426 CCG-P9426, NCT00002827
|
|
|
|
|
|
|
|
Last Modified: 5/14/2007  First Published: 3/1/1997 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Completed
|
|
|
|
21 and under
|
|
|
|
NCI
|
|
|
|
COG-9425 NCT00005578, POG-9425
|
|
|
|
|
|
|
|
Last Modified: 11/7/2007  First Published: 12/1/1999 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Closed
|
|
|
|
1 to 17
|
|
|
|
NCI
|
|
|
|
DFCI-95001 DFCI-FDR001197, NCI-G99-1651, NCT00004034
|
|
|
|
|
|
|
|
Last Modified: 5/18/2006  First Published: 8/1/1999 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Completed
|
|
|
|
30 and under
|
|
|
|
NCI
|
|
|
|
COG-P9754 POG-P9754, COG-P9754, CCG-P9754, NCT00003937, P9754
|
|
|
|
|
|
|
|
Last Modified: 5/9/2007  First Published: 5/1/2000 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Closed
|
|
|
|
25 and under at diagnosis
|
|
|
|
NCI
|
|
|
|
NCI-00-C-0092G AMGEN-20000124, NCT00020137
|
|
|
|
|
|
|
|
Last Modified: 8/2/2007  First Published: 5/1/2001 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
CLB-49808 NCT00016276, CALGB-49808
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
NYU-8305 NCI-T83-1038D, T83-1038
|
|
|
|